Condition: Limited-stage Small-cell Lung Cancer · Carcinoma, Small Cell Lung · Respiratory Tract Neoplasms · Sponsor: Fundación GECP
This is an open-label, phase II, exploratory and multi-centre clinical trial. 37 Limited stage SCLC patients not eligible for concurrent chemo-radiotherapy will be enroll. Patients will be enrolled in the trial after receiving sequential chemo-radiotherapy, if there is no progression disease, patients will be treated with maintenance Tarlatamab. Patients will receive maintenance with Tarlatamab IV until disease progression unacceptable toxicity, patient or physician decision to discontinue or death. The primary objective is to evaluate the Progression free survival (PFS). Patient accrual is expected to be completed within 2 years. Treatment and follow-up are expected to extend the study duration to a total of 5 years. Patients will be followed for 2 years after enrollment. The study will end once survival follow-up has concluded.
This description comes directly from the study's public registry record.
Eva Pereira · +34934302006 · gecp@gecp.org
Always discuss trial participation with your own doctor first.
| Hospital General Universitario de Albacete | Albacete, Albacete, Spain | Recruiting |
| Hospital General Universitario Dr. Balmis de Alicante | Alicante, Alicante, Spain | Recruiting |
| Hospital General Universitario de Elche | Elche, Alicante, Spain | Recruiting |
| Hospital de la Santa Creu i Sant Pau | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Barcelona, Spain | Recruiting |
| Fundació Althaia | Manresa, Barcelona, Spain | Recruiting |
| Hospital de Basurto | Bilbao, Bizkaia, Spain | Recruiting |
| Hospital Universitario de Jerez de la Frontera | Jerez de la Frontera, Cádiz, Spain | Recruiting |
| Hospital Universitario Lucus Augusti | Lugo, Lugo, Spain | Recruiting |
| Hospital Clínico San Carlos | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid, Madrid, Spain | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07242547